selinexor and Immunoglobulin-Light-chain-Amyloidosis

selinexor has been researched along with Immunoglobulin-Light-chain-Amyloidosis* in 1 studies

1 other study(ies) available for selinexor and Immunoglobulin-Light-chain-Amyloidosis

Article	Year
Safety, Tolerability, and Efficacy of Selinexor in a Patient With Relapsed Light Chain (AL) Amyloidosis. Clinical lymphoma, myeloma & leukemia, 2021, Volume: 21, Issue:5 Topics: Humans; Hydrazines; Immunoglobulin Light-chain Amyloidosis; Male; Middle Aged; Recurrence; Triazoles	2021